MURA Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 150876 min ago

@ $4.55

Išleistas: 14 vas. 2024 @ 19:08

Grąža: -21.32%

Ankstesnis signalas: vas. 14 - 16:34

Ankstesnis signalas: Pardavimas

Grąža: -0.44 %

Live Chart Being Loaded With Signals

Commentary (28 geg. 2024 @ 23:00):

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer...

Stats
Šios dienos apimtis	140 485
Vidutinė apimtis	196 652
Rinkos kapitalizacija	60.59M
EPS	$0 ( 2024-03-14 )
Kita pelno data	( $-2.66 ) 2024-06-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0100 (0.28%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-14	Cuss Francis M	Buy	15 021	Stock Option (right to buy)
2023-12-14	Jackson Scott Thomas	Buy	15 021	Stock Option (right to buy)
2023-12-14	Hickey Benjamin	Buy	15 021	Stock Option (right to buy)
2023-12-14	Cutler Adam D.	Buy	146 452	Stock Option (right to buy)
2023-12-14	Cutler Adam D.	Buy	78 859	Ordinary Shares

INSIDER POWER
100.00
Last 10 transactions
Buy: 353 823 \| Sell: 0

Tūris Koreliacija

Ilgas: -0.26 (neutral)

Trumpas: -0.97 (very strong negative)

Signal:(52.467) Neutral

Mural Oncology plc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Mural Oncology plc Koreliacija - Valiuta/Žaliavos

0.79
( moderate )

0.86
( strong )

0.00
( neutral )

-0.61
( weak negative )

0.55
( weak )

0.11
( neutral )

Mural Oncology plc Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-2.57M (0.00 %)
EPS:	$-12.43

FY	2023
Pajamos:	$0
Bruto pelnas:	$-2.57M (0.00 %)
EPS:	$-12.43

FY	2022
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-11.99

Financial Reports:

No articles found.

Mural Oncology plc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Mural Oncology plc

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company\'s lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.